1.
Am J Trop Med Hyg
; 106(5_Suppl): 39-47, 2022 05 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35292579
RESUMO
We discuss the experience of some Pacific island countries in introducing the new WHO-recommended treatment protocol for lymphatic filariasis-a triple-drug therapy composed of ivermectin, diethylcarbamazine, and albendazole. The successful rollout of the new treatment protocol was dependent on strong partnerships among these countries' ministries of health, WHO, and other stakeholders. Effective communication among these partners allowed for lessons learned to cross borders and have a positive impact on the experiences of other countries. We also describe various challenges confronted during this process and the ways these countries overcame them.
Assuntos
Filariose Linfática , Filaricidas , Humanos , Filariose Linfática/tratamento farmacológico , Filariose Linfática/epidemiologia , Filariose Linfática/prevenção & controle , Filaricidas/uso terapêutico , Dietilcarbamazina/uso terapêutico , Albendazol/uso terapêutico , Ivermectina/uso terapêutico , Quimioterapia Combinada
2.
MMWR Morb Mortal Wkly Rep
; 69(21): 656-657, 2020 05 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32463808